OmniAb

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

Our mission is to accelerate biomedical research by providing superior antibody services to our customers.

Our vision is to be the industry leader in discovering higher quality antibodies and developing better products for the biomedical research and biopharmaceutical industries.

OmniAb has been recognized for its commitment to quality and innovation with multiple awards, including the San Diego Business Journal's 'Most Innovative Companies of 2016' and Fast Company's 'Most Innovative Companies of 2019.'